EnableComp acquires H/ROI to expand clinical denials and DRG validation services
Deal adds Northeast-based clinical denials expertise and post-bill DRG validation to EnableComp’s complex revenue cycle offerings EnableComp intends to…
Alphaeon survey reports that patients delay or skip medical care due to cost
Respondents also reported difficulty paying medical bills and expressed interest in easier payment options, including financing offered through care…
Agentic AI Future in Pharma–HCP Engagement?
Doceree360 report outlines six transformative shifts that will redefine pharmaceutical marketing by 2027 Doceree, the AI-powered operating system for…
Survey Shows Growing Patient Preference for Tele dermatology Options
National poll finds access barriers and wait times driving interest in virtual dermatology care Nov. 18, 2025 — Miiskin…
NuraLogix Launches 20-Year Cardiovascular Risk Index to Advance Predictive Heart Health Monitoring
Toronto, ON — NuraLogix, a company developing contactless health insight technology, has introduced a new multi-year cardiovascular disease (CVD)…
SGLT2 Inhibitors Linked to Modestly Lower Risk of Autoimmune Rheumatic Diseases in Type 2 Diabetes Patients
A large population-based Korean study has found that patients with type 2 diabetes starting on SGLT2 inhibitors had a…
